Robeco Institutional Asset Management B.V. Purchases 14,809 Shares of Intuitive Surgical, Inc. (NASDAQ:ISRG)

Robeco Institutional Asset Management B.V. grew its position in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 5.0% in the fourth quarter, according to its most recent filing with the SEC. The fund owned 313,370 shares of the medical equipment provider’s stock after acquiring an additional 14,809 shares during the quarter. Robeco Institutional Asset Management B.V. owned about 0.09% of Intuitive Surgical worth $163,567,000 at the end of the most recent reporting period.

Other hedge funds and other institutional investors have also recently modified their holdings of the company. Mirador Capital Partners LP lifted its position in Intuitive Surgical by 1.4% in the third quarter. Mirador Capital Partners LP now owns 3,526 shares of the medical equipment provider’s stock worth $1,732,000 after buying an additional 50 shares during the last quarter. M.E. Allison & CO. Inc. bought a new stake in Intuitive Surgical in the fourth quarter worth $449,000. Seilern Investment Management Ltd bought a new stake in Intuitive Surgical in the fourth quarter worth $82,517,000. Exome Asset Management LLC lifted its position in Intuitive Surgical by 16.8% in the third quarter. Exome Asset Management LLC now owns 7,427 shares of the medical equipment provider’s stock worth $3,649,000 after buying an additional 1,069 shares during the last quarter. Finally, Consolidated Planning Corp lifted its position in Intuitive Surgical by 17.4% in the third quarter. Consolidated Planning Corp now owns 8,099 shares of the medical equipment provider’s stock worth $3,979,000 after buying an additional 1,198 shares during the last quarter. 83.64% of the stock is currently owned by institutional investors.

Insider Buying and Selling

In other Intuitive Surgical news, CFO Jamie Samath sold 270 shares of the business’s stock in a transaction that occurred on Tuesday, December 10th. The stock was sold at an average price of $540.15, for a total value of $145,840.50. Following the completion of the transaction, the chief financial officer now directly owns 8,757 shares of the company’s stock, valued at approximately $4,730,093.55. The trade was a 2.99 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, Director Amal M. Johnson sold 4,635 shares of the business’s stock in a transaction that occurred on Tuesday, January 28th. The shares were sold at an average price of $566.60, for a total value of $2,626,191.00. Following the completion of the transaction, the director now directly owns 12,275 shares of the company’s stock, valued at $6,955,015. The trade was a 27.41 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold 28,749 shares of company stock valued at $15,303,875 over the last quarter. 0.90% of the stock is currently owned by company insiders.

Analyst Upgrades and Downgrades

Several research firms have recently weighed in on ISRG. Robert W. Baird lifted their target price on Intuitive Surgical from $503.00 to $565.00 and gave the stock an “outperform” rating in a research report on Thursday, October 17th. Citigroup raised their price target on Intuitive Surgical from $640.00 to $711.00 and gave the company a “buy” rating in a research note on Friday, January 24th. UBS Group raised their price target on Intuitive Surgical from $500.00 to $560.00 and gave the company a “neutral” rating in a research note on Monday. Piper Sandler restated an “overweight” rating and set a $670.00 price target (up previously from $538.00) on shares of Intuitive Surgical in a research note on Friday, January 24th. Finally, Jefferies Financial Group raised their price target on Intuitive Surgical from $475.00 to $575.00 in a research note on Monday. One investment analyst has rated the stock with a sell rating, five have issued a hold rating and sixteen have given a buy rating to the company’s stock. Based on data from MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and an average price target of $613.10.

Intuitive Surgical Stock Up 0.1 %

Intuitive Surgical stock opened at $574.14 on Wednesday. Intuitive Surgical, Inc. has a 52 week low of $364.17 and a 52 week high of $616.00. The company has a market capitalization of $204.50 billion, a price-to-earnings ratio of 92.31, a price-to-earnings-growth ratio of 5.19 and a beta of 1.39. The stock has a 50-day moving average price of $548.70 and a 200 day moving average price of $507.04.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.